PATH vs WVE · P/E 19, rev $1.61B vs rev $108.3M
Uipath Inc (PATH) versus Wave Life Sciences Ltd (WVE) — a side-by-side from cached financials, not a winner call.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Wave Life Sciences Ltd (WVE) is a biotechnology company listed on NASDAQ.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Latest reported WVE revenue for 2024-12-31 was $108.3M. Net income was -$97.0M. Revenue was down 4.4% from 2023-12-31 to 2024-12-31. WVE currently screens at market cap $1.13B.
PATH currently screens at market cap $6.07B and trailing P/E 19.4. WVE currently screens at market cap $1.13B.
Not investment advice. Open the PATH and WVE stock pages for the full models.
Not investment advice.